Knowledge

Monoamine oxidase B

Source 📝

2182:
as the (adjacent) MAOB gene (Lenders et al., 1996). These patients did not exhibit any overt psychopathological alterations, pointing to a lack of overt clinical sequelae of MAOB deficiency (Lenders et al., 1996). ... The behavioral sequelae of MAO B deficiency are unlikely to be reflective of early neurodevelopmental problems (given the lower expression of this enzyme in perinatal stages), but may instead reflect tonic enhancements of PEA and/or other MAO B substrates. PEA is a trace amine that has been involved in several neuropsychiatric disorders (Beckmann et al., 1983; Szymanski et al., 1987; O'Reilly et al., 1991; Berry, 2007). The effects of PEA are not fully clear, but its chemical similarity with d-amphetamine (in which a methyl group is substituted at the α-carbon) underlines the possibility that this molecule may serve as a facilitator of catecholamine and serotonin release. On the other hand, the identification of TAAR1 as the endogenous receptor for PEA, as well as other monoamines metabolized by MAO B (such as tyramine and 3-iodothyronamine), calls into question whether the effects of PEA may result from a combination of different mechanisms.
2318:
bioavailability of tyramine is increased, which leads to an excess in NE, resulting in a hypertensive crisis (55, 217). Currently, they are not first-line antidepressant medications, and their use is limited to treatment-resistant or atypical depression. ... Selegiline is a selective MAO-B at low doses and a non-selective MAOI at higher doses; it also induces dopaminergic activity at low doses. This different action, depending on the dose, implies different use: low doses (up to 10 mg/day) for Parkinson's disease and higher doses as antidepressant treatment (Table 1) (55). ... Higher doses of oral and transdermal selegiline have been linked to a major frequency of orthostatic hypotension (227). No hypertensive crisis was reported with patch administration, but a small portion of patients with preexisting hypertension showed a worse BP control (224).
2029:
also exists in catecholaminergic neurons, such as dopaminergic neurons in SN, norepinephrine neurons in locus coeruleus, etc. . MAO-B is mainly distributed in platelets and glial cells, and total MAO activity within the brain is composed of approximately 20% MAO-A and 80% MAO-B . Both MAO-A and MAO-B regulate the amine neurotransmitters, including dopamine. MAO-A metabolizes dopamine in presynaptic neurons, while MAO-B metabolizes dopamine released to synaptic cleft and taken up by glial cells. The number of glial cells was shown to increase with age, and in neurodegenerative diseases, as expected, the activity of MAO-B also increased . MAO-B inhibitors inhibit MAO-B activity in the brain, block dopamine catabolism, enhance dopamine signaling, and selectively enhance dopamine levels at synaptic cleft .
467: 444: 341: 366: 718: 473: 372: 1668: 1676: 1660: 42: 1505:, and dopamine (and other less clinically relevant chemicals). In contrast, MAO-B metabolizes dopamine and phenethylamine, as well as other less clinically relevant chemicals. The differences between the substrate selectivity of the two enzymes are utilized clinically when treating specific disorders; MAO-A 3112:
To the best of our knowledge, there have been no reports of clinical conditions characterized by selective MAO-B deficiency. However, in few cases of atypical ND with MAO-B deletion, the latter deficit was reported to result in increased urinary excretion of PEA, but no overt behavioral abnormalities
1517:
as a result of excessive norepinephrine. Likewise, the consumption of tyramine-containing substances, such as cheese, whilst using MAO-A inhibitors also carries the risk of hypertensive crisis. Selective MAO-B inhibitors bypass this problem by preferentially inhibiting MAO-B, which allows tyramine to
2181:
In striking contrast with the evidence on MAOA deficiency, the clinical consequences of low MAO B activity remain partially elusive. Indeed, the only cases with a documented loss-of-function mutation were described in atypical Norrie disease patients, harboring deletions of both the ND gene as well
2028:
There are two MAO isoenzymes: MAO-A and MAO-B. MAO-A is mainly distributed in the gastrointestinal tract, platelets, and heart, and can promote the metabolism of tyramine-containing substances in food so avoiding hypertensive crises caused by the accumulation of tyramine ("cheese reaction"). MAO-A
2317:
The risk of developing the "cheese reaction" during treatment with MAOIs depends on the concurrent consumption of meals containing tyramine or sympathomimetic drugs (Table 3). Tyramine is normally metabolized by MAO-A located on the gut wall and by MAO-B in the liver; if MAO-A is inhibited, the
3458:
Leonetti F, Capaldi C, Pisani L, Nicolotti O, Muncipinto G, Stefanachi A, Cellamare S, Caccia C, Carotti A (October 2007). "Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase".
68: 3776:
Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Cirilli R, La Torre F, Cardia MC, Distinto S (November 2005). "Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of
3531:
Carotti A, Catto M, Leonetti F, Campagna F, Soto-Otero R, Méndez-Alvarez E, Thull U, Testa B, Altomare C (November 2007). "Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives".
3690:
Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F, Cardia MC, Distinto S (February 2007). "Selective inhibitory activity against MAO and molecular modeling studies of 2-thiazolylhydrazone derivatives".
3848:
Catto M, Nicolotti O, Leonetti F, Carotti A, Favia AD, Soto-Otero R, Méndez-Alvarez E, Carotti A (2006). "Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches".
3643:
Chimenti F, Secci D, Bolasco A, Chimenti P, Granese A, Carradori S, Yáñez M, Orallo F, Sanna ML, Gallinella B, Cirilli R (September 2010). "Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B:
3495:
Frédérick R, Dumont W, Ooms F, Aschenbach L, Van der Schyf CJ, Castagnoli N, Wouters J, Krief A (June 2006). "Synthesis, structural reassignment, and biological activity of type B MAO inhibitors based on the 5H-indenopyridazin-5-one core".
2330:
Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, et al. (September 1994). "Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography".
3735:
Chimenti F, Fioravanti R, Bolasco A, Manna F, Chimenti P, Secci D, Befani O, Turini P, Ortuso F, Alcaro S (February 2007). "Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole inhibitors".
3293:
Carotti A, Carrieri A, Chimichi S, Boccalini M, Cosimelli B, Gnerre C, Carotti A, Carrupt PA, Testa B (December 2002). "Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies".
1345:. Depending on the substrate or bound inhibitor, it can exist in either an open or a closed form, which has been shown to be important in defining the inhibitor specificity of hMAO-B. At the end of the substrate cavity is the 4238:
Pretorius J, Malan SF, Castagnoli N, Bergh JJ, Petzer JP (September 2008). "Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues".
3257:
Novaroli L, Daina A, Favre E, Bravo J, Carotti A, Leonetti F, Catto M, Carrupt PA, Reist M (October 2006). "Impact of species-dependent differences on screening, design, and development of MAO B inhibitors".
1627:
and behavioral abnormalities, people lacking the gene for MAO-B display no abnormalities except elevated phenethylamine levels in urine. Newer research indicates the importance of phenethylamine and other
3603:
Silvestri R, La Regina G, De Martino G, Artico M, Befani O, Palumbo M, Agostinelli E, Turini P (March 2003). "Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B".
4274:
Tzvetkov NT, Hinz S, Küppers P, Gastreich M, Müller CE (August 2014). "Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency".
4203:
Vlok N, Malan SF, Castagnoli N, Bergh JJ, Petzer JP (May 2006). "Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC)".
1604:
Transgenic mice that are unable to produce MAO-B are shown to be resistant to a mouse model of Parkinson's disease. They also demonstrate increased responsiveness to stress (as with MAO-A
1509:
have been typically used in the treatment of depression, whereas MAO-B inhibitors are typically used in the treatment of Parkinson's disease. Concurrent use of MAO-A inhibitors with
3567:
Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yáñez M, Orallo F, Ortuso F, Alcaro S (May 2009). "Chalcones: a valid scaffold for monoamine oxidases inhibitors".
2796:
Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC (October 1997). "Increased stress response and beta-phenylethylamine in MAOB-deficient mice".
3955:
Matos MJ, Viña D, Picciau C, Orallo F, Santana L, Uriarte E (September 2009). "Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors".
1294:
and plays an important role in the catabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. This protein preferentially degrades
3990:
Matos MJ, Viña D, Quezada E, Picciau C, Delogu G, Orallo F, Santana L, Uriarte E (June 2009). "A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors".
2423:
Nagatsu T, Sawada M (2006). "Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: Possible implications of glial cells".
480: 379: 3812:
Mishra N, Sasmal D (April 2011). "Development of selective and reversible pyrazoline based MAO-B inhibitors: virtual screening, synthesis and biological evaluation".
1615:
Inhibition of MAO-B in rats has been shown to prevent many age-related biological changes such as optic nerve degeneration, and extend average lifespan by up to 39%.
3027:
Kitani K, Kanai S, Sato Y, Ohta M, Ivy GO, Carrillo MC (1993). "Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats. Further evidence".
1651:
The prophylactic use of MAO-B inhibitors to slow natural human aging in otherwise healthy individuals has been proposed, but remains a highly controversial topic.
1349:
cofactor with sites for favorable amine binding about the flavin involving two nearly parallel tyrosyl (398 and 435) residues that form what has been termed an
4026:
Gaspar A, Reis J, Fonseca A, Milhazes N, Viña D, Uriarte E, Borges F (January 2011). "Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors".
3329:
Uebelhack R, Franke L, Schewe HJ (September 1998). "Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)".
3920:
Matos MJ, Viña D, Janeiro P, Borges F, Santana L, Uriarte E (September 2010). "New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors".
3885:
Matos MJ, Vazquez-Rodriguez S, Uriarte E, Santana L, Viña D (July 2011). "MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins".
991: 302: 972: 3201:
Ukraintseva SV, Arbeev KG, Michalsky AI, Yashin AI (June 2004). "Antiaging treatments have been legally prescribed for approximately thirty years".
3423:
van Diermen D, Marston A, Bravo J, Reist M, Carrupt PA, Hostettmann K (March 2009). "Monoamine oxidase inhibition by Rhodiola rosea L. roots".
2676:"Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels" 1951: 3087: 2440: 4168:
Strydom B, Malan SF, Castagnoli N, Bergh JJ, Petzer JP (February 2010). "Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues".
1933: 1318:
Monoamine oxidase B has a hydrophobic bipartite elongated cavity that (for the "open" conformation) occupies a combined volume close to 700
4314: 4062:
Manley-King CI, Bergh JJ, Petzer JP (January 2011). "Inhibition of monoamine oxidase by selected C5- and C6-substituted isatin analogues".
3127:"The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity" 1566: 466: 2097:"Structure-function relationships in flavoenzyme-dependent amine oxidations: A comparison of polyamine oxidase and monoamine oxidase" 1191: 1198: 443: 1969: 3374:"Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of garlic extract in mice" 2194:
Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM (1993). "Reversible monoamine oxidase-A inhibitors in resistant major depression".
1920: 1899: 4098:
Manley-King CI, Bergh JJ, Petzer JP (August 2011). "Inhibition of monoamine oxidase by C5-substituted phthalimide analogues".
1916: 4133:
Strydom B, Bergh JJ, Petzer JP (August 2011). "8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase".
2484:
Kumar MJ, Andersen JK (August 2004). "Perspectives on MAO-B in aging and neurological disease: where do we go from here?".
365: 340: 65: 1322:. hMAO-A has a single cavity that exhibits a rounder shape and is larger in volume than the "substrate cavity" of hMAO-B. 1895: 1280: 282: 1573:, responsible for the development of plaques, observed in Alzheimer's and Parkinson's patients. Evidence suggests that 1506: 1346: 1592:), slows the progression, improves and reverses the symptoms, associated with AD and PD, including the reduction of 479: 378: 1624: 472: 371: 2894:
Shih JC (January 2004). "Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B.".
1036: 290: 1561:
and increased levels of MAO-B in the brain have also been linked to the accumulation of amyloid β-peptides (
1538: 1017: 1830: 1546: 1537:(PD) are both associated with elevated levels of MAO-B in the brain. The normal activity of MAO-B creates 1534: 1530: 1519: 2674:
Schedin-Weiss S, Inoue M, Hromadkova L, Teranishi Y, Yamamoto NG, Wiehager B, et al. (August 2017).
2529:"Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans" 2143:"From aggression to autism: new perspectives on the behavioral sequelae of monoamine oxidase deficiency" 1574: 1284: 1541:, which directly damage cells. MAO-B levels have been found to increase with age, suggesting a role in 1444:
This reaction is believed to occur in three steps. First, the amine is oxidized to the corresponding
3210: 1510: 354: 2376:"Metabolic control analysis in a cellular model of elevated MAO-B: relevance to Parkinson's disease" 1990:"Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future" 269: 2931:"Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice" 1872: 1514: 1303: 2766:
Shih JC, Chen K (1999). "MAO-A and -B gene knock-out mice exhibit distinctly different behavior".
3354: 3234: 2821: 2627:"Monoamine oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts" 2509: 2458: 2356: 1702: 314: 1174: 1153: 1127: 1106: 2578:"Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury" 2275:
Calvi A, Fischetti I, Verzicco I, Belvederi Murri M, Zanetidou S, Volpi R, et al. (2021).
4291: 4256: 4220: 4185: 4150: 4115: 4079: 4043: 4007: 3972: 3937: 3902: 3866: 3829: 3794: 3753: 3716: 3671: 3620: 3584: 3549: 3513: 3476: 3440: 3405: 3346: 3311: 3275: 3226: 3183: 3156: 3103: 3083: 3044: 3009: 2960: 2911: 2873: 2813: 2775: 2748: 2707: 2656: 2607: 2558: 2501: 2446: 2436: 2405: 2348: 2308: 2252: 2203: 2172: 2118: 2077: 2019: 1637: 1557:. Activity of MAO-B has also been shown to play a role in stress-induced cardiac damage. Over- 1554: 1372: 1272: 262: 58: 2727:"Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review)" 2625:
Kaludercic N, Carpi A, Nagayama T, Sivakumaran V, Zhu G, Lai EW, et al. (January 2014).
4283: 4248: 4212: 4177: 4142: 4107: 4071: 4035: 3999: 3964: 3929: 3894: 3858: 3821: 3786: 3745: 3708: 3700: 3661: 3653: 3612: 3576: 3541: 3505: 3468: 3432: 3395: 3385: 3338: 3303: 3267: 3218: 3146: 3138: 3093: 3075: 3036: 2999: 2991: 2980:"Monoamine oxidase enzymes and oxidative stress in the rat optic nerve: age-related changes" 2950: 2942: 2903: 2863: 2855: 2805: 2738: 2697: 2687: 2646: 2638: 2597: 2589: 2548: 2540: 2493: 2428: 2395: 2387: 2340: 2298: 2288: 2242: 2234: 2162: 2154: 2108: 2067: 2059: 2009: 2001: 1581: 1545:
and the increased likelihood of developing neurological diseases later in life. More active
1542: 1367:, the initial step in the breakdown of these molecules. The products are the corresponding 559: 490: 434: 389: 2470: 1612:. In addition, they exhibit behavioral disinhibition and reduced anxiety-like behaviors. 1570: 1558: 717: 534: 310: 2048:"Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B" 3214: 3064:"Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence" 3400: 3373: 3151: 3126: 3098: 3079: 3063: 3004: 2979: 2955: 2930: 2868: 2843: 2839: 2702: 2675: 2651: 2626: 2602: 2577: 2553: 2528: 2400: 2375: 2303: 2276: 2247: 2222: 2167: 2142: 2072: 2047: 2014: 1989: 1609: 1605: 1577: 1498: 1319: 1299: 3307: 2907: 906: 901: 896: 891: 886: 881: 876: 871: 866: 861: 856: 851: 846: 841: 825: 820: 815: 810: 805: 800: 795: 779: 774: 769: 764: 759: 4308: 3142: 3040: 2995: 2344: 1633: 746: 3358: 3238: 2825: 2513: 2374:
Mallajosyula JK, Chinta SJ, Rajagopalan S, Nicholls DG, Andersen JK (October 2009).
2360: 2859: 1683:
Species-dependent divergences may hamper the extrapolation of inhibitor potencies.
1679:
Structural formulae of high-affinity reversible MAO inhibitors selective for type B
1593: 1562: 1550: 552: 331: 294: 4146: 2593: 318: 2432: 1956:
National Center for Biotechnology Information, U.S. National Library of Medicine
1938:
National Center for Biotechnology Information, U.S. National Library of Medicine
1817: 1697: 1641: 1629: 1295: 4039: 4003: 3968: 3933: 3898: 3825: 1803:
Phenylcoumarins, extremely subtype selective and further analogs (see 3d model)
1675: 635: 4252: 4216: 4181: 4111: 4075: 3436: 2692: 2544: 2497: 2391: 2158: 2063: 1859: 1849: 1790: 1744: 1589: 1585: 1482: 1338: 1288: 451: 348: 298: 2293: 3390: 3222: 1727: 1667: 1502: 936: 695: 573: 518: 505: 417: 404: 306: 4295: 4260: 4224: 4189: 4154: 4119: 4083: 4047: 4011: 3976: 3941: 3906: 3870: 3833: 3798: 3757: 3720: 3675: 3624: 3588: 3553: 3517: 3480: 3444: 3409: 3315: 3279: 3230: 3187: 3160: 3107: 3013: 2964: 2915: 2877: 2779: 2752: 2711: 2660: 2611: 2562: 2505: 2450: 2409: 2312: 2256: 2238: 2176: 2122: 2113: 2096: 2081: 2023: 3350: 3342: 3048: 2817: 2743: 2726: 2642: 2352: 2207: 1238: 1233: 2946: 1806: 1797: 1785: 1758: 1716: 1712: 1494: 1368: 1307: 1222: 1081: 1062: 3712: 3666: 1659: 2978:
Nebbioso M, Pascarella A, Cavallotti C, Pescosolido N (December 2012).
2809: 2005: 1376: 1048: 1003: 4287: 3862: 3790: 3749: 3704: 3657: 3616: 3580: 3545: 3509: 3472: 3271: 239: 235: 231: 227: 223: 219: 215: 211: 207: 203: 199: 195: 191: 187: 183: 179: 175: 171: 167: 163: 159: 155: 151: 147: 143: 139: 135: 131: 127: 123: 119: 115: 111: 107: 103: 99: 95: 91: 87: 1812: 1722: 1364: 1357: 1276: 1258: 1206: 958: 17: 3777:
1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)- pyrazole derivatives".
2929:
Bortolato M, Godar SC, Davarian S, Chen K, Shih JC (December 2009).
2576:
Kaludercic N, Carpi A, Menabò R, Di Lisa F, Paolocci N (July 2011).
3113:
or cognitive deficits (Berger et al., 1992; Lenders et al., 1996).
1853: 1674: 1666: 1645: 1445: 1291: 921: 917: 1706: 1265: 286: 3644:
1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines".
726: 41: 2582:
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
1778:
1-(4-Arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazine
542: 1271:
The protein encoded by this gene belongs to the flavin
1306:(MAO-A), MAO-B is also involved in the catabolism of 707: 1167: 1146: 1120: 1099: 1912: 1910: 1908: 1891: 1889: 1887: 897:positive regulation of dopamine metabolic process 489: 388: 2277:"Antidepressant Drugs Effects on Blood Pressure" 2141:Bortolato M, Floris G, Shih JC (November 2018). 2136: 2134: 2132: 2095:Binda C, Mattevi A, Edmondson DE (5 July 2002). 2046:Edmondson DE, Binda C, Mattevi A (August 2007). 1623:While people lacking the gene for MAO-A display 3252: 3250: 3248: 2984:International Journal of Experimental Pathology 2527:Dlugos AM, Palmer AA, de Wit H (October 2009). 1549:of the MAO-B gene have been linked to negative 1456:accepts two electrons and two protons from FADH 1325:The first cavity of hMAO-B has been termed the 27:Protein-coding gene in the species Homo sapiens 2791: 2789: 2041: 2039: 2037: 1917:GRCm38: Ensembl release 89: ENSMUSG00000040147 2889: 2887: 2270: 2268: 2266: 8: 1485:by water, forming ammonia and the aldehyde. 1448:, with reduction of the FAD cofactor to FADH 2844:"Monoamine oxidase: from genes to behavior" 1896:GRCh38: Ensembl release 89: ENSG00000069535 1829:)-8-(4-phenylbutadien-1-yl)caffeines, with 1553:, and suspected as an underlying factor in 1481:and regenerating FAD. Third, the imine is 1983: 1981: 1979: 1363:-dependent oxidation of primary arylalkyl 932: 862:negative regulation of serotonin secretion 742: 530: 429: 326: 76: 3665: 3399: 3389: 3150: 3097: 3003: 2954: 2867: 2742: 2701: 2691: 2650: 2601: 2552: 2399: 2302: 2292: 2246: 2166: 2112: 2071: 2013: 1658: 2223:"MAO-inhibitors in Parkinson's Disease" 1970:"Entrez Gene: MAOB monoamine oxidase B" 1883: 2466: 2456: 1754:-Indenopyridazin-5-ones (see 3d model) 1518:be metabolized freely by MAO-A in the 882:hydrogen peroxide biosynthetic process 31: 1543:natural age related cognitive decline 494: 455: 450: 393: 352: 347: 7: 4241:Bioorganic & Medicinal Chemistry 3068:International Review of Neurobiology 2425:Oxidative Stress and Neuroprotection 2281:Frontiers in Cardiovascular Medicine 1822:8-Benzyloxycaffeines and CSC analogs 1800:derivatives and #C19* (see 3d model) 1839:Indazole- and Indole-5-carboxamides 1584:of MAO-B through MAO-B inhibitors ( 1567:amyloid precursor protein secretase 765:flavin adenine dinucleotide binding 3372:Dhingra D, Kumar V (August 2008). 3080:10.1016/B978-0-12-386467-3.00002-9 2680:Alzheimer's Research & Therapy 2631:Antioxidants & Redox Signaling 1988:Tan YY, Jenner P, Chen SD (2022). 1632:, which are now known to regulate 1164: 1143: 1117: 1096: 1072: 1053: 1027: 1008: 982: 963: 902:neurotransmitter catabolic process 712: 630: 568: 547: 25: 2221:Riederer P, Laux G (March 2011). 1489:Differences between MAOA and MAOB 1261:that in humans is encoded by the 760:protein homodimerization activity 3143:10.1111/j.1471-4159.2010.07109.x 2996:10.1111/j.1365-2613.2012.00832.x 2427:. Vol. 71. pp. 53–65. 716: 478: 471: 465: 442: 377: 370: 364: 339: 40: 2101:Journal of Biological Chemistry 1619:Effects of deficiency in humans 4276:Journal of Medicinal Chemistry 3851:Journal of Medicinal Chemistry 3534:Journal of Medicinal Chemistry 3461:Journal of Medicinal Chemistry 3378:Indian Journal of Pharmacology 3174:Miklya I (December 2009). "". 2860:10.1146/annurev.neuro.22.1.197 2533:Journal of Neural Transmission 2147:Journal of Neural Transmission 1994:Journal of Parkinson's Disease 867:response to lipopolysaccharide 796:integral component of membrane 780:primary amine oxidase activity 727:More reference expression data 696:More reference expression data 1: 3308:10.1016/S0960-894X(02)00798-9 3062:Bortolato M, Shih JC (2011). 2908:10.1016/s0161-813x(03)00112-8 2848:Annual Review of Neuroscience 1640:through the same receptor as 1565:), through mechanisms of the 646:epithelium of small intestine 463: 362: 4147:10.1016/j.ejmech.2011.05.014 3425:Journal of Ethnopharmacology 3041:10.1016/0024-3205(93)90219-S 2594:10.1016/j.bbamcr.2010.09.010 2345:10.1016/0306-4522(94)90311-5 1493:MAO-A generally metabolizes 1356:Like MAO-A, MAO-B catalyzes 1281:outer mitochondrial membrane 847:substantia nigra development 816:mitochondrial inner membrane 806:mitochondrial outer membrane 654:Epithelium of choroid plexus 4315:Genes on human chromosome X 2433:10.1007/978-3-211-33328-0_7 1341:199 side-chain serves as a 1337:(~390 Å) – between both an 892:response to toxic substance 857:response to steroid hormone 612:superior vestibular nucleus 4331: 4040:10.1016/j.bmcl.2010.11.128 4004:10.1016/j.bmcl.2009.04.085 3969:10.1016/j.bmcl.2009.07.039 3934:10.1016/j.bmcl.2010.07.013 3899:10.1016/j.bmcl.2011.05.074 3826:10.1016/j.bmcl.2011.02.030 3125:Miller GM (January 2011). 2842:, Chen K, Ridd MJ (1999). 2731:Molecular Medicine Reports 1526:Roles in disease and aging 877:dopamine catabolic process 852:response to corticosterone 770:electron transfer activity 4253:10.1016/j.bmc.2008.07.088 4217:10.1016/j.bmc.2006.01.011 4182:10.1016/j.bmc.2009.12.064 4112:10.1016/j.bmc.2011.06.070 4076:10.1016/j.bmc.2010.11.028 3437:10.1016/j.jep.2009.01.007 3176:Neuropsychopharmacol Hung 2693:10.1186/s13195-017-0279-1 2545:10.1007/s00702-009-0281-2 2392:10.1007/s12640-009-9032-2 2159:10.1007/s00702-018-1888-y 2064:10.1016/j.abb.2007.05.006 1952:"Mouse PubMed Reference:" 1934:"Human PubMed Reference:" 1625:intellectual disabilities 1237: 1232: 1228: 1221: 1205: 1186: 1171: 1150: 1139: 1124: 1103: 1092: 1079: 1075: 1060: 1056: 1047: 1034: 1030: 1015: 1011: 1002: 989: 985: 970: 966: 957: 942: 935: 931: 915: 745: 741: 724: 715: 706: 693: 642: 633: 580: 571: 541: 533: 529: 512: 499: 462: 441: 432: 428: 411: 398: 361: 338: 329: 325: 280: 277: 267: 260: 255: 84: 79: 62: 57: 52: 48: 39: 34: 2294:10.3389/fcvm.2021.704281 1709:extract; modest affinity 907:electron transport chain 872:response to aluminum ion 842:response to selenium ion 588:external globus pallidus 4028:Bioorg. Med. Chem. Lett 3992:Bioorg. Med. Chem. Lett 3957:Bioorg. Med. Chem. Lett 3922:Bioorg. Med. Chem. Lett 3887:Bioorg. Med. Chem. Lett 3814:Bioorg. Med. Chem. Lett 3391:10.4103/0253-7613.43165 3296:Bioorg. Med. Chem. Lett 3223:10.1196/annals.1297.014 2935:Neuropsychopharmacology 1844:Irreversible (covalent) 1539:reactive oxygen species 1199:Chr X: 16.58 – 16.68 Mb 1192:Chr X: 43.77 – 43.88 Mb 775:oxidoreductase activity 682:myocardium of ventricle 678:interventricular septum 658:upper respiratory tract 2486:Molecular Neurobiology 2380:Neurotoxicity Research 2239:10.5607/en.2011.20.1.1 2114:10.1074/jbc.R200005200 2052:Arch. Biochem. Biophys 1836:antagonistic component 1680: 1672: 1664: 1596:plaques in the brain. 1520:gastrointestinal tract 1314:Structure and Function 821:mitochondrial envelope 496:X A1.2|X 11.88 cM 3343:10.1055/s-2007-979325 2744:10.3892/mmr.2014.2040 2643:10.1089/ars.2012.4616 1809:-3-phenylcarboxamides 1771:-benzylaminomethyl)-1 1678: 1670: 1662: 1285:oxidative deamination 826:extracellular exosome 670:medial dorsal nucleus 273:, Monoamine oxidase B 3203:Ann. N. Y. Acad. Sci 2947:10.1038/npp.2009.118 1852:(Eldepryl, Zelapar, 1781:2-Thiazolylhydrazone 1655:Selective inhibitors 1329:(290 Å), the second 666:olfactory epithelium 600:middle frontal gyrus 457:X chromosome (mouse) 355:X chromosome (human) 80:List of PDB id codes 53:Available structures 3215:2004NYASA1019...64U 2498:10.1385/MN:30:1:077 2202:(Suppl 2): S69–76. 2196:Clin Neuropharmacol 2107:(27): 23973–23976. 1873:Monoamine oxidase A 1705:, a constituent of 1535:Parkinson's disease 1531:Alzheimer's disease 1515:hypertensive crisis 1513:drugs can induce a 1304:monoamine oxidase A 1283:. It catalyzes the 1251:Monoamine oxidase B 887:response to ethanol 674:islet of Langerhans 620:right lobe of liver 4024:compound #9, #12, 3331:Pharmacopsychiatry 2810:10.1038/ng1097-206 2725:Cai Z (May 2014). 2006:10.3233/JPD-212976 1703:Desmethoxyyangonin 1681: 1673: 1665: 1335:active site cavity 1037:ENSMUSG00000040147 835:Biological process 789:Cellular component 753:Molecular function 650:left lobe of liver 596:tail of epididymis 4288:10.1021/jm500729a 4282:(15): 6679–6703. 4205:Bioorg. Med. Chem 4170:Bioorg. Med. Chem 4100:Bioorg. Med. Chem 4064:Bioorg. Med. Chem 3863:10.1021/jm060183l 3791:10.1021/jm040903t 3750:10.1021/jm060868l 3705:10.1021/jm060869d 3658:10.1021/jm100120s 3617:10.1021/jm0256124 3581:10.1021/jm801590u 3546:10.1021/jm070728r 3510:10.1021/jm051091j 3473:10.1021/jm070725e 3272:10.1021/jm060441e 3089:978-0-12-386467-3 2768:Neurobiology (Bp) 2539:(10): 1323–1334. 2442:978-3-211-33327-3 2153:(11): 1589–1599. 1638:neurotransmission 1608:) and increased 1373:hydrogen peroxide 1275:family. It is an 1273:monoamine oxidase 1248: 1247: 1244: 1243: 1217: 1216: 1182: 1181: 1161: 1160: 1135: 1134: 1114: 1113: 1088: 1087: 1069: 1068: 1043: 1042: 1024: 1023: 998: 997: 979: 978: 927: 926: 737: 736: 733: 732: 702: 701: 689: 688: 627: 626: 525: 524: 424: 423: 251: 250: 247: 246: 63:Ortholog search: 16:(Redirected from 4322: 4300: 4299: 4271: 4265: 4264: 4235: 4229: 4228: 4200: 4194: 4193: 4165: 4159: 4158: 4130: 4124: 4123: 4094: 4088: 4087: 4058: 4052: 4051: 4022: 4016: 4015: 3987: 3981: 3980: 3952: 3946: 3945: 3917: 3911: 3910: 3881: 3875: 3874: 3844: 3838: 3837: 3809: 3803: 3802: 3768: 3762: 3761: 3731: 3725: 3724: 3686: 3680: 3679: 3669: 3635: 3629: 3628: 3599: 3593: 3592: 3564: 3558: 3557: 3528: 3522: 3521: 3491: 3485: 3484: 3455: 3449: 3448: 3420: 3414: 3413: 3403: 3393: 3369: 3363: 3362: 3326: 3320: 3319: 3290: 3284: 3283: 3254: 3243: 3242: 3198: 3192: 3191: 3178:(in Hungarian). 3171: 3165: 3164: 3154: 3122: 3116: 3115: 3101: 3059: 3053: 3052: 3024: 3018: 3017: 3007: 2975: 2969: 2968: 2958: 2926: 2920: 2919: 2891: 2882: 2881: 2871: 2836: 2830: 2829: 2793: 2784: 2783: 2763: 2757: 2756: 2746: 2722: 2716: 2715: 2705: 2695: 2671: 2665: 2664: 2654: 2622: 2616: 2615: 2605: 2588:(7): 1323–1332. 2573: 2567: 2566: 2556: 2524: 2518: 2517: 2481: 2475: 2474: 2468: 2464: 2462: 2454: 2420: 2414: 2413: 2403: 2371: 2365: 2364: 2327: 2321: 2320: 2306: 2296: 2272: 2261: 2260: 2250: 2218: 2212: 2211: 2191: 2185: 2184: 2170: 2138: 2127: 2126: 2116: 2092: 2086: 2085: 2075: 2043: 2032: 2031: 2017: 1985: 1974: 1973: 1966: 1960: 1959: 1948: 1942: 1941: 1930: 1924: 1914: 1903: 1893: 1480: 1479: 1478: 1470: 1469: 1440: 1439: 1438: 1428: 1427: 1426: 1418: 1417: 1407: 1405: 1404: 1394: 1393: 1392: 1331:substrate cavity 1287:of biogenic and 1253:, also known as 1230: 1229: 1201: 1194: 1177: 1165: 1156: 1144: 1140:RefSeq (protein) 1130: 1118: 1109: 1097: 1073: 1054: 1028: 1009: 983: 964: 933: 743: 729: 720: 713: 698: 662:nasal epithelium 638: 636:Top expressed in 631: 576: 574:Top expressed in 569: 548: 531: 521: 508: 497: 482: 475: 469: 458: 446: 430: 420: 407: 396: 381: 374: 368: 357: 343: 327: 321: 319:MAOB - orthologs 272: 265: 242: 77: 71: 50: 49: 44: 32: 21: 4330: 4329: 4325: 4324: 4323: 4321: 4320: 4319: 4305: 4304: 4303: 4273: 4272: 4268: 4247:(18): 8676–84. 4237: 4236: 4232: 4211:(10): 3512–21. 4202: 4201: 4197: 4167: 4166: 4162: 4132: 4131: 4127: 4106:(16): 4829–40. 4097: 4095: 4091: 4061: 4059: 4055: 4025: 4023: 4019: 3998:(12): 3268–70. 3989: 3988: 3984: 3954: 3953: 3949: 3928:(17): 5157–60. 3919: 3918: 3914: 3884: 3882: 3878: 3857:(16): 4912–25. 3847: 3845: 3841: 3811: 3810: 3806: 3785:(23): 7113–22. 3775: 3769: 3765: 3734: 3732: 3728: 3689: 3687: 3683: 3652:(17): 6516–20. 3642: 3636: 3632: 3602: 3600: 3596: 3566: 3565: 3561: 3540:(22): 5364–71. 3530: 3529: 3525: 3494: 3492: 3488: 3467:(20): 4909–16. 3457: 3456: 3452: 3422: 3421: 3417: 3371: 3370: 3366: 3328: 3327: 3323: 3292: 3291: 3287: 3266:(21): 6264–72. 3256: 3255: 3246: 3200: 3199: 3195: 3173: 3172: 3168: 3124: 3123: 3119: 3090: 3061: 3060: 3056: 3026: 3025: 3021: 2977: 2976: 2972: 2941:(13): 2746–57. 2928: 2927: 2923: 2896:Neurotoxicology 2893: 2892: 2885: 2838: 2837: 2833: 2798:Nature Genetics 2795: 2794: 2787: 2765: 2764: 2760: 2724: 2723: 2719: 2673: 2672: 2668: 2624: 2623: 2619: 2575: 2574: 2570: 2526: 2525: 2521: 2483: 2482: 2478: 2465: 2455: 2443: 2422: 2421: 2417: 2373: 2372: 2368: 2329: 2328: 2324: 2274: 2273: 2264: 2220: 2219: 2215: 2193: 2192: 2188: 2140: 2139: 2130: 2094: 2093: 2089: 2045: 2044: 2035: 1987: 1986: 1977: 1968: 1967: 1963: 1950: 1949: 1945: 1932: 1931: 1927: 1915: 1906: 1894: 1885: 1881: 1869: 1846: 1834: 1741: 1694: 1689: 1657: 1621: 1602: 1528: 1511:sympathomimetic 1491: 1477: 1474: 1473: 1472: 1468: 1465: 1464: 1463: 1461: 1459: 1455: 1451: 1437: 1434: 1433: 1432: 1430: 1425: 1422: 1421: 1420: 1416: 1413: 1412: 1411: 1409: 1403: 1400: 1399: 1398: 1396: 1391: 1388: 1387: 1386: 1384: 1361: 1327:entrance cavity 1316: 1279:located in the 1239:View/Edit Mouse 1234:View/Edit Human 1197: 1190: 1187:Location (UCSC) 1173: 1152: 1126: 1105: 1018:ENSG00000069535 911: 830: 784: 725: 694: 685: 680: 676: 672: 668: 664: 660: 656: 652: 648: 634: 623: 618: 614: 610: 606: 602: 598: 594: 590: 586: 572: 516: 503: 495: 485: 484: 483: 476: 456: 433:Gene location ( 415: 402: 394: 384: 383: 382: 375: 353: 330:Gene location ( 281: 268: 261: 86: 64: 28: 23: 22: 15: 12: 11: 5: 4328: 4326: 4318: 4317: 4307: 4306: 4302: 4301: 4266: 4230: 4195: 4176:(3): 1018–28. 4160: 4141:(8): 3474–85. 4135:Eur J Med Chem 4125: 4096:compound #5c, 4089: 4060:compound #9i, 4053: 4017: 3982: 3963:(17): 5053–5. 3947: 3912: 3893:(14): 4224–7. 3876: 3846:compound #41, 3839: 3820:(7): 1969–73. 3804: 3763: 3733:compound #3g, 3726: 3688:compound #18, 3681: 3630: 3601:compound #21, 3594: 3575:(9): 2818–24. 3559: 3523: 3504:(12): 3743–7. 3493:compound #2d, 3486: 3450: 3431:(2): 397–401. 3415: 3384:(4): 175–179. 3364: 3321: 3302:(24): 3551–5. 3285: 3244: 3193: 3166: 3137:(2): 164–176. 3117: 3088: 3054: 3019: 2970: 2921: 2902:(1–2): 21–30. 2883: 2831: 2785: 2758: 2737:(5): 1533–41. 2717: 2666: 2637:(2): 267–280. 2617: 2568: 2519: 2476: 2467:|journal= 2441: 2415: 2386:(3): 186–193. 2366: 2322: 2262: 2213: 2186: 2128: 2087: 2033: 2000:(2): 477–493. 1975: 1961: 1943: 1925: 1904: 1882: 1880: 1877: 1876: 1875: 1868: 1865: 1864: 1863: 1857: 1845: 1842: 1841: 1840: 1837: 1832: 1823: 1820: 1815: 1810: 1804: 1801: 1794: 1788: 1782: 1779: 1776: 1761: 1755: 1748: 1740: 1737: 1736: 1735: 1725: 1720: 1710: 1700: 1693: 1690: 1688: 1685: 1656: 1653: 1636:and serotonin 1620: 1617: 1601: 1598: 1527: 1524: 1499:norepinephrine 1490: 1487: 1475: 1466: 1457: 1453: 1449: 1442: 1441: 1435: 1423: 1414: 1401: 1389: 1359: 1315: 1312: 1302:. Similar to 1300:phenethylamine 1246: 1245: 1242: 1241: 1236: 1226: 1225: 1219: 1218: 1215: 1214: 1212: 1210: 1203: 1202: 1195: 1188: 1184: 1183: 1180: 1179: 1169: 1168: 1162: 1159: 1158: 1148: 1147: 1141: 1137: 1136: 1133: 1132: 1122: 1121: 1115: 1112: 1111: 1101: 1100: 1094: 1090: 1089: 1086: 1085: 1077: 1076: 1070: 1067: 1066: 1058: 1057: 1051: 1045: 1044: 1041: 1040: 1032: 1031: 1025: 1022: 1021: 1013: 1012: 1006: 1000: 999: 996: 995: 987: 986: 980: 977: 976: 968: 967: 961: 955: 954: 949: 944: 940: 939: 929: 928: 925: 924: 913: 912: 910: 909: 904: 899: 894: 889: 884: 879: 874: 869: 864: 859: 854: 849: 844: 838: 836: 832: 831: 829: 828: 823: 818: 813: 808: 803: 798: 792: 790: 786: 785: 783: 782: 777: 772: 767: 762: 756: 754: 750: 749: 739: 738: 735: 734: 731: 730: 722: 721: 710: 704: 703: 700: 699: 691: 690: 687: 686: 684: 683: 679: 675: 671: 667: 663: 659: 655: 651: 647: 643: 640: 639: 628: 625: 624: 622: 621: 617: 613: 609: 605: 601: 597: 593: 589: 585: 584:saphenous vein 581: 578: 577: 565: 564: 556: 545: 539: 538: 535:RNA expression 527: 526: 523: 522: 514: 510: 509: 501: 498: 493: 487: 486: 477: 470: 464: 460: 459: 454: 448: 447: 439: 438: 426: 425: 422: 421: 413: 409: 408: 400: 397: 392: 386: 385: 376: 369: 363: 359: 358: 351: 345: 344: 336: 335: 323: 322: 279: 275: 274: 266: 258: 257: 253: 252: 249: 248: 245: 244: 82: 81: 73: 72: 61: 55: 54: 46: 45: 37: 36: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 4327: 4316: 4313: 4312: 4310: 4297: 4293: 4289: 4285: 4281: 4277: 4270: 4267: 4262: 4258: 4254: 4250: 4246: 4242: 4234: 4231: 4226: 4222: 4218: 4214: 4210: 4206: 4199: 4196: 4191: 4187: 4183: 4179: 4175: 4171: 4164: 4161: 4156: 4152: 4148: 4144: 4140: 4136: 4129: 4126: 4121: 4117: 4113: 4109: 4105: 4101: 4093: 4090: 4085: 4081: 4077: 4073: 4070:(1): 261–74. 4069: 4065: 4057: 4054: 4049: 4045: 4041: 4037: 4033: 4029: 4021: 4018: 4013: 4009: 4005: 4001: 3997: 3993: 3986: 3983: 3978: 3974: 3970: 3966: 3962: 3958: 3951: 3948: 3943: 3939: 3935: 3931: 3927: 3923: 3916: 3913: 3908: 3904: 3900: 3896: 3892: 3888: 3883:compound #2, 3880: 3877: 3872: 3868: 3864: 3860: 3856: 3852: 3843: 3840: 3835: 3831: 3827: 3823: 3819: 3815: 3808: 3805: 3800: 3796: 3792: 3788: 3784: 3780: 3773: 3767: 3764: 3759: 3755: 3751: 3747: 3743: 3739: 3730: 3727: 3722: 3718: 3714: 3710: 3706: 3702: 3699:(4): 707–12. 3698: 3694: 3685: 3682: 3677: 3673: 3668: 3663: 3659: 3655: 3651: 3647: 3640: 3634: 3631: 3626: 3622: 3618: 3614: 3611:(6): 917–20. 3610: 3606: 3598: 3595: 3590: 3586: 3582: 3578: 3574: 3570: 3563: 3560: 3555: 3551: 3547: 3543: 3539: 3535: 3527: 3524: 3519: 3515: 3511: 3507: 3503: 3499: 3490: 3487: 3482: 3478: 3474: 3470: 3466: 3462: 3454: 3451: 3446: 3442: 3438: 3434: 3430: 3426: 3419: 3416: 3411: 3407: 3402: 3397: 3392: 3387: 3383: 3379: 3375: 3368: 3365: 3360: 3356: 3352: 3348: 3344: 3340: 3337:(5): 187–92. 3336: 3332: 3325: 3322: 3317: 3313: 3309: 3305: 3301: 3297: 3289: 3286: 3281: 3277: 3273: 3269: 3265: 3261: 3253: 3251: 3249: 3245: 3240: 3236: 3232: 3228: 3224: 3220: 3216: 3212: 3208: 3204: 3197: 3194: 3189: 3185: 3182:(4): 217–25. 3181: 3177: 3170: 3167: 3162: 3158: 3153: 3148: 3144: 3140: 3136: 3132: 3128: 3121: 3118: 3114: 3109: 3105: 3100: 3095: 3091: 3085: 3081: 3077: 3073: 3069: 3065: 3058: 3055: 3050: 3046: 3042: 3038: 3034: 3030: 3023: 3020: 3015: 3011: 3006: 3001: 2997: 2993: 2989: 2985: 2981: 2974: 2971: 2966: 2962: 2957: 2952: 2948: 2944: 2940: 2936: 2932: 2925: 2922: 2917: 2913: 2909: 2905: 2901: 2897: 2890: 2888: 2884: 2879: 2875: 2870: 2865: 2861: 2857: 2853: 2849: 2845: 2841: 2835: 2832: 2827: 2823: 2819: 2815: 2811: 2807: 2804:(2): 206–10. 2803: 2799: 2792: 2790: 2786: 2781: 2777: 2774:(2): 235–46. 2773: 2769: 2762: 2759: 2754: 2750: 2745: 2740: 2736: 2732: 2728: 2721: 2718: 2713: 2709: 2704: 2699: 2694: 2689: 2685: 2681: 2677: 2670: 2667: 2662: 2658: 2653: 2648: 2644: 2640: 2636: 2632: 2628: 2621: 2618: 2613: 2609: 2604: 2599: 2595: 2591: 2587: 2583: 2579: 2572: 2569: 2564: 2560: 2555: 2550: 2546: 2542: 2538: 2534: 2530: 2523: 2520: 2515: 2511: 2507: 2503: 2499: 2495: 2491: 2487: 2480: 2477: 2472: 2460: 2452: 2448: 2444: 2438: 2434: 2430: 2426: 2419: 2416: 2411: 2407: 2402: 2397: 2393: 2389: 2385: 2381: 2377: 2370: 2367: 2362: 2358: 2354: 2350: 2346: 2342: 2338: 2334: 2326: 2323: 2319: 2314: 2310: 2305: 2300: 2295: 2290: 2286: 2282: 2278: 2271: 2269: 2267: 2263: 2258: 2254: 2249: 2244: 2240: 2236: 2232: 2228: 2227:Exp Neurobiol 2224: 2217: 2214: 2209: 2205: 2201: 2197: 2190: 2187: 2183: 2178: 2174: 2169: 2164: 2160: 2156: 2152: 2148: 2144: 2137: 2135: 2133: 2129: 2124: 2120: 2115: 2110: 2106: 2102: 2098: 2091: 2088: 2083: 2079: 2074: 2069: 2065: 2061: 2058:(2): 269–76. 2057: 2053: 2049: 2042: 2040: 2038: 2034: 2030: 2025: 2021: 2016: 2011: 2007: 2003: 1999: 1995: 1991: 1984: 1982: 1980: 1976: 1971: 1965: 1962: 1957: 1953: 1947: 1944: 1939: 1935: 1929: 1926: 1922: 1918: 1913: 1911: 1909: 1905: 1901: 1897: 1892: 1890: 1888: 1884: 1878: 1874: 1871: 1870: 1866: 1861: 1858: 1855: 1851: 1848: 1847: 1843: 1838: 1835: 1828: 1824: 1821: 1819: 1816: 1814: 1811: 1808: 1805: 1802: 1799: 1795: 1792: 1789: 1787: 1783: 1780: 1777: 1774: 1770: 1766: 1762: 1760: 1756: 1753: 1749: 1746: 1743: 1742: 1738: 1733: 1729: 1726: 1724: 1721: 1718: 1714: 1711: 1708: 1704: 1701: 1699: 1696: 1695: 1691: 1686: 1684: 1677: 1669: 1661: 1654: 1652: 1649: 1647: 1643: 1639: 1635: 1634:catecholamine 1631: 1626: 1618: 1616: 1613: 1611: 1607: 1606:knockout mice 1600:Animal models 1599: 1597: 1595: 1591: 1587: 1583: 1580:of MAO-B, or 1579: 1576: 1572: 1568: 1564: 1560: 1556: 1552: 1548: 1547:polymorphisms 1544: 1540: 1536: 1532: 1525: 1523: 1521: 1516: 1512: 1508: 1504: 1500: 1496: 1488: 1486: 1484: 1447: 1408:→ Aldehyde + 1382: 1381: 1380: 1378: 1374: 1370: 1366: 1362: 1354: 1352: 1351:aromatic cage 1348: 1344: 1340: 1336: 1332: 1328: 1323: 1321: 1313: 1311: 1309: 1305: 1301: 1297: 1293: 1290: 1286: 1282: 1278: 1274: 1269: 1267: 1264: 1260: 1256: 1252: 1240: 1235: 1231: 1227: 1224: 1220: 1213: 1211: 1208: 1204: 1200: 1196: 1193: 1189: 1185: 1178: 1176: 1170: 1166: 1163: 1157: 1155: 1149: 1145: 1142: 1138: 1131: 1129: 1123: 1119: 1116: 1110: 1108: 1102: 1098: 1095: 1093:RefSeq (mRNA) 1091: 1084: 1083: 1078: 1074: 1071: 1065: 1064: 1059: 1055: 1052: 1050: 1046: 1039: 1038: 1033: 1029: 1026: 1020: 1019: 1014: 1010: 1007: 1005: 1001: 994: 993: 988: 984: 981: 975: 974: 969: 965: 962: 960: 956: 953: 950: 948: 945: 941: 938: 934: 930: 923: 919: 914: 908: 905: 903: 900: 898: 895: 893: 890: 888: 885: 883: 880: 878: 875: 873: 870: 868: 865: 863: 860: 858: 855: 853: 850: 848: 845: 843: 840: 839: 837: 834: 833: 827: 824: 822: 819: 817: 814: 812: 811:mitochondrion 809: 807: 804: 802: 799: 797: 794: 793: 791: 788: 787: 781: 778: 776: 773: 771: 768: 766: 763: 761: 758: 757: 755: 752: 751: 748: 747:Gene ontology 744: 740: 728: 723: 719: 714: 711: 709: 705: 697: 692: 681: 677: 673: 669: 665: 661: 657: 653: 649: 645: 644: 641: 637: 632: 629: 619: 615: 611: 607: 603: 599: 595: 591: 587: 583: 582: 579: 575: 570: 567: 566: 563: 561: 557: 555: 554: 550: 549: 546: 544: 540: 536: 532: 528: 520: 515: 511: 507: 502: 492: 488: 481: 474: 468: 461: 453: 449: 445: 440: 436: 431: 427: 419: 414: 410: 406: 401: 391: 387: 380: 373: 367: 360: 356: 350: 346: 342: 337: 333: 328: 324: 320: 316: 312: 308: 304: 300: 296: 292: 288: 284: 276: 271: 264: 259: 254: 243: 241: 237: 233: 229: 225: 221: 217: 213: 209: 205: 201: 197: 193: 189: 185: 181: 177: 173: 169: 165: 161: 157: 153: 149: 145: 141: 137: 133: 129: 125: 121: 117: 113: 109: 105: 101: 97: 93: 89: 83: 78: 75: 74: 70: 67: 60: 56: 51: 47: 43: 38: 33: 30: 19: 4279: 4275: 4269: 4244: 4240: 4233: 4208: 4204: 4198: 4173: 4169: 4163: 4138: 4134: 4128: 4103: 4099: 4092: 4067: 4063: 4056: 4034:(2): 707–9. 4031: 4027: 4020: 3995: 3991: 3985: 3960: 3956: 3950: 3925: 3921: 3915: 3890: 3886: 3879: 3854: 3850: 3842: 3817: 3813: 3807: 3782: 3779:J. Med. Chem 3778: 3771: 3766: 3744:(3): 425–8. 3741: 3738:J. Med. Chem 3737: 3729: 3713:11573/231039 3696: 3693:J. Med. Chem 3692: 3684: 3667:11573/360702 3649: 3646:J. Med. Chem 3645: 3638: 3637:compound # ( 3633: 3608: 3605:J. Med. Chem 3604: 3597: 3572: 3569:J. Med. Chem 3568: 3562: 3537: 3533: 3526: 3501: 3498:J. Med. Chem 3497: 3489: 3464: 3460: 3453: 3428: 3424: 3418: 3381: 3377: 3367: 3334: 3330: 3324: 3299: 3295: 3288: 3263: 3260:J. Med. Chem 3259: 3206: 3202: 3196: 3179: 3175: 3169: 3134: 3131:J. Neurochem 3130: 3120: 3111: 3071: 3067: 3057: 3035:(3): 281–8. 3032: 3028: 3022: 2990:(6): 401–5. 2987: 2983: 2973: 2938: 2934: 2924: 2899: 2895: 2851: 2847: 2834: 2801: 2797: 2771: 2767: 2761: 2734: 2730: 2720: 2683: 2679: 2669: 2634: 2630: 2620: 2585: 2581: 2571: 2536: 2532: 2522: 2492:(1): 77–89. 2489: 2485: 2479: 2424: 2418: 2383: 2379: 2369: 2339:(1): 15–30. 2336: 2333:Neuroscience 2332: 2325: 2316: 2284: 2280: 2230: 2226: 2216: 2199: 2195: 2189: 2180: 2150: 2146: 2104: 2100: 2090: 2055: 2051: 2027: 1997: 1993: 1964: 1955: 1946: 1937: 1928: 1826: 1818:Phthalimides 1772: 1768: 1764: 1757:Substituted 1751: 1731: 1682: 1671:(+)-Catechin 1650: 1630:trace amines 1622: 1614: 1603: 1551:emotionality 1529: 1492: 1452:. Second, O 1443: 1355: 1350: 1342: 1334: 1330: 1326: 1324: 1317: 1270: 1262: 1254: 1250: 1249: 1172: 1151: 1125: 1104: 1080: 1061: 1035: 1016: 990: 971: 951: 946: 604:hypothalamus 558: 551: 278:External IDs 85: 29: 3770:compound #( 3209:(1): 64–9. 2854:: 197–217. 2233:(1): 1–17. 1793:derivatives 1784:3,5-Diaryl 1747:and analogs 1717:epicatechin 1698:Geiparvarin 1663:Geiparvarin 1642:amphetamine 1571:γ-secretase 1296:benzylamine 517:16,683,605 504:16,575,521 416:43,882,450 403:43,766,610 256:Identifiers 2287:: 704281. 1923:, May 2017 1902:, May 2017 1879:References 1860:Rasagiline 1850:Selegiline 1791:Pyrazoline 1745:Safinamide 1687:Reversible 1590:Rasagiline 1582:inhibition 1559:expression 1555:depression 1507:inhibitors 1483:hydrolyzed 1460:, forming 1339:isoleucine 1289:xenobiotic 608:left ovary 562:(ortholog) 299:HomoloGene 3074:: 13–42. 2686:(1): 57. 2469:ignored ( 2459:cite book 1862:(Azilect) 1759:chalcones 1739:Synthetic 1728:Rosiridin 1586:Selegline 1578:silencing 1533:(AD) and 1503:serotonin 1175:NP_766366 1154:NP_000889 1128:NM_172778 1107:NM_000898 937:Orthologs 307:GeneCards 4309:Category 4296:24955776 4261:18723354 4225:16442801 4190:20093036 4155:21621312 4120:21778064 4084:21134756 4048:21194943 4012:19423346 3977:19628387 3942:20659799 3907:21684743 3871:16884303 3834:21377879 3799:16279769 3758:17266193 3721:17253676 3676:20715818 3625:12620068 3589:19378991 3554:17910428 3518:16759116 3481:17824599 3445:19168123 3410:20040952 3359:25270815 3316:12443774 3280:17034132 3239:25181147 3231:15246996 3188:20150659 3161:21073468 3108:21971001 3029:Life Sci 3014:23082958 2965:19710633 2916:14697877 2878:10202537 2826:31804364 2780:10591056 2753:24626484 2712:28764767 2661:23581564 2612:20869994 2563:19657584 2514:19776473 2506:15247489 2451:17447416 2410:19526285 2361:38740469 2313:34414219 2257:22110357 2177:29748850 2123:12015330 2082:17573034 2024:34957948 1919:– 1898:– 1867:See also 1807:Chromone 1798:coumarin 1796:Several 1786:pyrazole 1775:-pyrrole 1767:-Methyl- 1732:in vitro 1713:Catechin 1495:tyramine 1383:Amine + 1369:aldehyde 1308:dopamine 1257:, is an 1223:Wikidata 916:Sources: 801:membrane 3401:2792615 3351:9832350 3211:Bibcode 3152:3005101 3099:3371272 3049:8423709 3005:3521895 2956:2783894 2869:2844879 2840:Shih JC 2818:9326944 2703:5540560 2652:3887464 2603:3030628 2554:3653168 2401:2727365 2353:7816197 2304:8370473 2248:3213739 2208:8313400 2168:6215718 2073:1993809 2015:8925102 1921:Ensembl 1900:Ensembl 1813:Isatins 1692:Natural 1377:ammonia 1049:UniProt 1004:Ensembl 943:Species 922:QuickGO 592:decidua 537:pattern 263:Aliases 4294:  4259:  4223:  4188:  4153:  4118:  4082:  4046:  4010:  3975:  3940:  3905:  3869:  3832:  3797:  3756:  3719:  3674:  3641:)-8b, 3623:  3587:  3552:  3516:  3479:  3443:  3408:  3398:  3357:  3349:  3314:  3278:  3237:  3229:  3186:  3159:  3149:  3106:  3096:  3086:  3047:  3012:  3002:  2963:  2953:  2914:  2876:  2866:  2824:  2816:  2778:  2751:  2710:  2700:  2659:  2649:  2610:  2600:  2561:  2551:  2512:  2504:  2449:  2439:  2408:  2398:  2359:  2351:  2311:  2301:  2255:  2245:  2206:  2175:  2165:  2121:  2080:  2070:  2022:  2012:  1723:Garlic 1375:, and 1365:amines 1292:amines 1277:enzyme 1259:enzyme 1209:search 1207:PubMed 1082:Q8BW75 1063:P27338 992:109731 959:Entrez 708:BioGPS 395:Xp11.3 287:309860 3774:)-1, 3355:S2CID 3235:S2CID 2822:S2CID 2510:S2CID 2357:S2CID 1854:Emsam 1646:TAAR1 1610:β-PEA 1575:siRNA 1446:imine 1255:MAO-B 952:Mouse 947:Human 918:Amigo 616:liver 560:Mouse 553:Human 500:Start 435:Mouse 399:Start 332:Human 303:20251 295:96916 18:MAO-B 4292:PMID 4257:PMID 4221:PMID 4186:PMID 4151:PMID 4116:PMID 4080:PMID 4044:PMID 4008:PMID 3973:PMID 3938:PMID 3903:PMID 3867:PMID 3830:PMID 3795:PMID 3754:PMID 3717:PMID 3672:PMID 3621:PMID 3585:PMID 3550:PMID 3514:PMID 3477:PMID 3441:PMID 3406:PMID 3347:PMID 3312:PMID 3276:PMID 3227:PMID 3207:1019 3184:PMID 3157:PMID 3104:PMID 3084:ISBN 3045:PMID 3010:PMID 2961:PMID 2912:PMID 2874:PMID 2814:PMID 2776:PMID 2749:PMID 2708:PMID 2657:PMID 2608:PMID 2586:1813 2559:PMID 2502:PMID 2471:help 2447:PMID 2437:ISBN 2406:PMID 2349:PMID 2309:PMID 2253:PMID 2204:PMID 2173:PMID 2119:PMID 2078:PMID 2020:PMID 1715:and 1707:kava 1343:gate 1298:and 1266:gene 1263:MAOB 973:4129 543:Bgee 491:Band 452:Chr. 390:Band 349:Chr. 311:MAOB 283:OMIM 270:MAOB 240:4CRT 236:4A7A 232:4A79 228:3ZYX 224:3PO7 220:2XFU 216:2XFQ 212:2XFP 208:2XFO 204:2XFN 200:2XCG 196:2VZ2 192:2VRM 188:2VRL 184:2V61 180:2V60 176:2V5Z 172:2C76 168:2C75 164:2C73 160:2C72 156:2C70 152:2C67 148:2C66 144:2C65 140:2C64 136:2BYB 132:2BK5 128:2BK4 124:2BK3 120:1S3E 116:1S3B 112:1S2Y 108:1S2Q 104:1OJD 100:1OJC 96:1OJA 92:1OJ9 88:1GOS 69:RCSB 66:PDBe 35:MAOB 4284:doi 4249:doi 4213:doi 4178:doi 4143:doi 4108:doi 4072:doi 4036:doi 4000:doi 3965:doi 3930:doi 3895:doi 3859:doi 3822:doi 3787:doi 3746:doi 3709:hdl 3701:doi 3662:hdl 3654:doi 3613:doi 3577:doi 3542:doi 3506:doi 3469:doi 3433:doi 3429:122 3396:PMC 3386:doi 3339:doi 3304:doi 3268:doi 3219:doi 3147:PMC 3139:doi 3135:116 3094:PMC 3076:doi 3072:100 3037:doi 3000:PMC 2992:doi 2951:PMC 2943:doi 2904:doi 2864:PMC 2856:doi 2806:doi 2739:doi 2698:PMC 2688:doi 2647:PMC 2639:doi 2598:PMC 2590:doi 2549:PMC 2541:doi 2537:116 2494:doi 2429:doi 2396:PMC 2388:doi 2341:doi 2299:PMC 2289:doi 2243:PMC 2235:doi 2163:PMC 2155:doi 2151:125 2109:doi 2105:277 2068:PMC 2060:doi 2056:464 2010:PMC 2002:doi 1827:E,E 1763:2-( 1347:FAD 1333:or 513:End 412:End 315:OMA 291:MGI 59:PDB 4311:: 4290:. 4280:57 4278:. 4255:. 4245:16 4243:. 4219:. 4209:14 4207:. 4184:. 4174:18 4172:. 4149:. 4139:46 4137:. 4114:. 4104:19 4102:. 4078:. 4068:19 4066:. 4042:. 4032:21 4030:. 4006:. 3996:19 3994:. 3971:. 3961:19 3959:. 3936:. 3926:20 3924:. 3901:. 3891:21 3889:. 3865:. 3855:49 3853:. 3828:. 3818:21 3816:. 3793:. 3783:48 3781:. 3752:. 3742:50 3740:. 3715:. 3707:. 3697:50 3695:. 3670:. 3660:. 3650:53 3648:. 3619:. 3609:46 3607:. 3583:. 3573:52 3571:. 3548:. 3538:50 3536:. 3512:. 3502:49 3500:. 3475:. 3465:50 3463:. 3439:. 3427:. 3404:. 3394:. 3382:40 3380:. 3376:. 3353:. 3345:. 3335:31 3333:. 3310:. 3300:12 3298:. 3274:. 3264:49 3262:. 3247:^ 3233:. 3225:. 3217:. 3205:. 3180:11 3155:. 3145:. 3133:. 3129:. 3110:. 3102:. 3092:. 3082:. 3070:. 3066:. 3043:. 3033:52 3031:. 3008:. 2998:. 2988:93 2986:. 2982:. 2959:. 2949:. 2939:34 2937:. 2933:. 2910:. 2900:25 2898:. 2886:^ 2872:. 2862:. 2852:22 2850:. 2846:. 2820:. 2812:. 2802:17 2800:. 2788:^ 2770:. 2747:. 2733:. 2729:. 2706:. 2696:. 2682:. 2678:. 2655:. 2645:. 2635:20 2633:. 2629:. 2606:. 2596:. 2584:. 2580:. 2557:. 2547:. 2535:. 2531:. 2508:. 2500:. 2490:30 2488:. 2463:: 2461:}} 2457:{{ 2445:. 2435:. 2404:. 2394:. 2384:16 2382:. 2378:. 2355:. 2347:. 2337:62 2335:. 2315:. 2307:. 2297:. 2283:. 2279:. 2265:^ 2251:. 2241:. 2231:20 2229:. 2225:. 2200:16 2198:. 2179:. 2171:. 2161:. 2149:. 2145:. 2131:^ 2117:. 2103:. 2099:. 2076:. 2066:. 2054:. 2050:. 2036:^ 2026:. 2018:. 2008:. 1998:12 1996:. 1992:. 1978:^ 1954:. 1936:. 1907:^ 1886:^ 1833:2A 1648:. 1644:, 1594:Aβ 1588:, 1569:, 1563:Aβ 1522:. 1501:, 1497:, 1431:NH 1429:+ 1395:+ 1379:: 1371:, 1353:. 1310:. 1268:. 920:/ 519:bp 506:bp 418:bp 405:bp 313:; 309:: 305:; 301:: 297:; 293:: 289:; 285:: 238:, 234:, 230:, 226:, 222:, 218:, 214:, 210:, 206:, 202:, 198:, 194:, 190:, 186:, 182:, 178:, 174:, 170:, 166:, 162:, 158:, 154:, 150:, 146:, 142:, 138:, 134:, 130:, 126:, 122:, 118:, 114:, 110:, 106:, 102:, 98:, 94:, 90:, 4298:. 4286:: 4263:. 4251:: 4227:. 4215:: 4192:. 4180:: 4157:. 4145:: 4122:. 4110:: 4086:. 4074:: 4050:. 4038:: 4014:. 4002:: 3979:. 3967:: 3944:. 3932:: 3909:. 3897:: 3873:. 3861:: 3836:. 3824:: 3801:. 3789:: 3772:S 3760:. 3748:: 3723:. 3711:: 3703:: 3678:. 3664:: 3656:: 3639:R 3627:. 3615:: 3591:. 3579:: 3556:. 3544:: 3520:. 3508:: 3483:. 3471:: 3447:. 3435:: 3412:. 3388:: 3361:. 3341:: 3318:. 3306:: 3282:. 3270:: 3241:. 3221:: 3213:: 3190:. 3163:. 3141:: 3078:: 3051:. 3039:: 3016:. 2994:: 2967:. 2945:: 2918:. 2906:: 2880:. 2858:: 2828:. 2808:: 2782:. 2772:7 2755:. 2741:: 2735:9 2714:. 2690:: 2684:9 2663:. 2641:: 2614:. 2592:: 2565:. 2543:: 2516:. 2496:: 2473:) 2453:. 2431:: 2412:. 2390:: 2363:. 2343:: 2291:: 2285:8 2259:. 2237:: 2210:. 2157:: 2125:. 2111:: 2084:. 2062:: 2004:: 1972:. 1958:. 1940:. 1856:) 1831:A 1825:( 1773:H 1769:N 1765:N 1752:H 1750:5 1734:) 1730:( 1719:. 1476:2 1471:O 1467:2 1462:H 1458:2 1454:2 1450:2 1436:3 1424:2 1419:O 1415:2 1410:H 1406:O 1402:2 1397:H 1390:2 1385:O 1360:2 1358:O 1320:Å 437:) 334:) 317:: 20:)

Index

MAO-B

PDB
PDBe
RCSB
1GOS
1OJ9
1OJA
1OJC
1OJD
1S2Q
1S2Y
1S3B
1S3E
2BK3
2BK4
2BK5
2BYB
2C64
2C65
2C66
2C67
2C70
2C72
2C73
2C75
2C76
2V5Z
2V60
2V61

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.